Background Clinical trials have established the high effectiveness and safety of medication
abortion in clinical settings. However, barriers to clinical abortion care have shifted most …

Background To evaluate the feasibility of conducting a prospective study to measure self-
managed medication abortion outcomes, and to collect preliminary data on safety and …

Background As access to clinical abortion care becomes increasingly restricted in the United
States, the need for self-managed abortions (ie abortions taking place outside of the formal …

Background The advent of medical abortion has improved access to safe abortion
procedures. Medical abortion procedures involve either administering mifepristone followed …

Background Mifepristone-misoprostol abortion, consisting of oral pills, is potentially simple
and safe enough for use in less-developed countries. But the labour-intensive, costly, clinic …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

Objectives In most European countries, patients seeking medication abortion during the
COVID-19 pandemic are still required to attend healthcare settings in person. We assessed …

Objectives To document medication abortion clinical practice changes adopted by providers
in response to the COVID-19 pandemic. Study design Longitudinal descriptive study …

The COVID-19 pandemic is acutely threatening access to essential health services,
including abortion [1]. Across all fields of medicine, changes in practice models are …

Background Medical abortion is under-used in developing countries. We assessed whether
early first-trimester medical abortion provided by midlevel providers (government-trained …